Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.26 USD
Change Today -0.0149 / -5.44%
Volume 500.0
PBIO On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

pressure biosciences inc (PBIO) Snapshot

Open
$0.26
Previous Close
$0.28
Day High
$0.26
Day Low
$0.26
52 Week High
02/20/15 - $0.45
52 Week Low
10/20/14 - $0.13
Market Cap
5.1M
Average Volume 10 Days
36.1K
EPS TTM
$-0.37
Shares Outstanding
19.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PRESSURE BIOSCIENCES INC (PBIO)

Related News

No related news articles were found.

pressure biosciences inc (PBIO) Related Businessweek News

No Related Businessweek News Found

pressure biosciences inc (PBIO) Details

Pressure BioSciences, Inc. develops pressure cycling technology (PCT) in the United States. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples. The company offers Barocycler instrumentation products, including Barocycler NEP3229, Barocycler NEP2320, Barocycler HUB440, PCT MicroTube Adapter Kit, The Shredder SG3, Barocycler HUB880, Barozyme HT48, BaroFlex 8-well Processing Strips, and PCT-HD laboratory instrumentation that subjects a sample to cycles of pressure from ambient to ultra-high levels and then back to ambient. It also distributes Constant Systems cell disruption equipment, parts, and consumables. In addition, the company offers Baracycler consumable products, such as PULSE Tubes, which transmit the power of PCT from the Barocycler instrument to the sample; Non-Disk PULSE Tubes that offer variable sample volumes; ProteoSolve for Systems Biology, which is a PCT-dependent method for the simultaneous extraction, isolation, and fractionation of nucleic acids, proteins, and lipids from animal and plant samples used in laboratory research. Its Baracycler consumable products also include ProteoSolve for Conventional Extraction that is a PCT-dependent kit for the extraction of proteins from various samples; mitochondria isolation kits that contain the chemical ingredients required for a scientist to extract mitochondria from skeletal muscle and lung tissue for subsequent analysis; and PCT Micro-Pestle and PCT MicroTubes to enhance the extraction of protein, DNA, RNA, and small molecules from small amounts of solid samples, such as soft animal tissues or biopsies. Pressure BioSciences, Inc. serves researchers at academic laboratories; government agencies; biotechnology, pharmaceutical, and other life sciences companies. The company, formerly known as Boston Biomedica, Inc., was founded in 1978 and is based in South Easton, Massachusetts.

10 Employees
Last Reported Date: 03/31/15
Founded in 1978

pressure biosciences inc (PBIO) Top Compensated Officers

Founder, Chief Executive Officer, President, ...
Total Annual Compensation: $294.3K
Senior Vice President of Engineering
Total Annual Compensation: $197.6K
Vice President of Research and Development
Total Annual Compensation: $165.6K
Compensation as of Fiscal Year 2014.

pressure biosciences inc (PBIO) Key Developments

MaloneBailey, LLP Replaces Marcum LLP as Pressure BioSciences, Inc.'s Independent Registered Public Accounting Firm

On June 23, 2015, the Board of Directors of Pressure BioSciences, Inc. dismissed Marcum LLP as its independent registered public accounting firm. On June 23, 2015, the Board of Directors of the company engaged MaloneBailey, LLP as its independent registered public accounting firm.

Pressure BioSciences, Inc. Presents at 3rd Global Life Sciences Conference, Jun-11-2015 07:40 AM

Pressure BioSciences, Inc. Presents at 3rd Global Life Sciences Conference, Jun-11-2015 07:40 AM. Venue: Warsaw Stock Exchange, Warsaw, Poland. Speakers: Richard T. Schumacher, Founder, Chief Executive Officer, President, Secretary, Treasurer, Clerk and Director.

Pressure BioSciences, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Pressure BioSciences, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported total revenue of $440,134 compared to $404,147 a year ago. Operating loss was $874,819 compared to $782,366 a year ago. Net loss was $2,047,455 compared to $1,759,655 a year ago. Net loss applicable to common shareholders was $2,064,123 compared to $3,084,708 a year ago. Net loss per share attributable to common stockholders - basic and diluted was $0.11 compared to $0.25 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PBIO:US $0.26 USD -0.0149

PBIO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PBIO.
View Industry Companies
 

Industry Analysis

PBIO

Industry Average

Valuation PBIO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PRESSURE BIOSCIENCES INC, please visit www.pressurebiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.